Tower Research Capital LLC (Trc) Anebulo Pharmaceuticals, Inc. Transaction History
Tower Research Capital LLC (Trc)
- $4.07 Billion
- Q1 2024
A detailed history of Tower Research Capital LLC (Trc) transactions in Anebulo Pharmaceuticals, Inc. stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 5,138 shares of ANEB stock, worth $12,793. This represents 0.0% of its overall portfolio holdings.
Number of Shares
5,138
Previous 9,102
43.55%
Holding current value
$12,793
Previous $22,000
36.36%
% of portfolio
0.0%
Previous 0.0%
Shares
12 transactions
Others Institutions Holding ANEB
# of Institutions
16Shares Held
7.31MCall Options Held
0Put Options Held
0-
22 Nw, LP Seattle, WA5.37MShares$13.4 Million15.16% of portfolio
-
Lvw Advisors, LLC642KShares$1.6 Million0.32% of portfolio
-
Nantahala Capital Management, LLC New Canaan, CT511KShares$1.27 Million0.09% of portfolio
-
Morgan Stanley New York, NY399KShares$994,0550.0% of portfolio
-
Ikarian Capital, LLC Dallas, TX158KShares$393,0760.06% of portfolio
About Anebulo Pharmaceuticals, Inc.
- Ticker ANEB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 25,633,200
- Market Cap $63.8M
- Description
- Anebulo Pharmaceuticals, Inc., a clinical-stage biotechnology company, engages in developing and commercializing treatments for people suffering from acute cannabinoid intoxication and substance addiction. Its lead product candidate is ANEB-001, a small molecule cannabinoid receptor antagonist to treat cannabinoid intoxication and overdose. The ...